Status:
COMPLETED
Pulmonary Vascular Impairment in Chronic Obstructive Pulmonary Disease (COPD) Assessed by MRI
Lead Sponsor:
Assistance Publique Hopitaux De Marseille
Conditions:
Chronic Obstructive Pulmonary Disease (COPD)
Eligibility:
All Genders
40-70 years
Phase:
NA
Brief Summary
Chronic Obstructive Pulmonary Disease (COPD) is a highly prevalent pulmonary disease providing major morbidity and mortality. Bronchial obstruction is the cornerstone in assessment of the disease wher...
Detailed Description
Chronic Obstructive Pulmonary Disease (COPD) is a highly prevalent pulmonary disease providing major morbidity and mortality. Bronchial obstruction is the cornerstone in assessment of the disease wher...
Eligibility Criteria
Inclusion
- Age 40-70
- Diagnosed with COPD
- Emphysema on chest CT
- FEV1 between 35 and 80 %
- Screened for PH by echocardiography
Exclusion
- side effect for exercise
- side effect for MRI and contrast agent injection
- Pregnancy or breastfeeding
- Refusing to be informed of the discovery of an anomaly on chest MRI
Key Trial Info
Start Date :
October 15 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 15 2025
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT04126616
Start Date
October 15 2019
End Date
October 15 2025
Last Update
November 19 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Assistance Publique Hôpitaux de Marseille
Marseille, France